scispace - formally typeset
D

Deepa Pookot

Researcher at University of California, San Francisco

Publications -  26
Citations -  3769

Deepa Pookot is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Prostate cancer & LNCaP. The author has an hindex of 17, co-authored 25 publications receiving 3503 citations.

Papers
More filters
Journal ArticleDOI

MicroRNA-373 induces expression of genes with complementary promoter sequences

TL;DR: Findings reveal a new mode by which miRNAs may regulate gene expression, and identify a miRNA that targets promoter sequences and induces gene expression.
Journal ArticleDOI

Small dsRNAs induce transcriptional activation in human cells

TL;DR: A more diverse role for small RNA molecules in the regulation of gene expression than previously recognized is revealed and a potential therapeutic use for dsRNA in targeted gene activation is identified.
Journal ArticleDOI

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

TL;DR: The data indicate that miR-449a regulates cell growth and viability in part by repressing the expression of HDAC-1 in prostate cancer cells, providing new insight into the function of miRNA in regulating HDAC expression in normal versus cancerous tissue.
Journal ArticleDOI

Genistein Induces the p21WAF1/CIP1 and p16INK4a Tumor Suppressor Genes in Prostate Cancer Cells by Epigenetic Mechanisms Involving Active Chromatin Modification

TL;DR: The data provide new insights into the epigenetic mechanism of the action of genistein that may contribute to the chemopreventive activity of this dietary isoflavone and have important implications for epigenetic therapy.
Journal ArticleDOI

Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity.

TL;DR: The findings suggest that aberrant AEG-1 expression plays a dominant role as a positive auto-feedback activator of AKT and as a suppressor of FOXO3a in PC cells, and may represent a novel genetic biomarker to serve as an attractive molecular target for new anticancer agents to prevent PC cell progression and metastasis.